Sponsor
Hennig Arzneimittel GmbH & Co. KG
Liebigstrasse 1-2, 65439, Germany
About the sponsor
Research activity is centred on comparative evaluation of an oral combination therapy, with attention to how the formulation behaves in the body under fed conditions.
- Cinnarizine and Dimenhydrinate tablet formulation
- Healthy participants
- Oral solid dosage form assessment
The sponsor’s clinical research interest is focused on therapeutic product performance rather than disease-specific treatment areas, reflecting work in generic medicines and formulation comparison.
Try clearing a filter, or search the whole catalogue.
Are you running a clinical trial?
Increase visibility for your trials and help patients find your site through our platform.
